Reply

We have reviewed the experience in a single center of a biologic register for rheumatoid arthritis patients. Over the past decade, the entry demographics show that we are treating patients at an earlier stage and with slightly less severe disease. Our outcomes measured by the percentage in DAS28 remission are comparable with national databases. We were surprised by the small number who were switched from their first biologic to a second (27 %), but this might reflect the lack of a firm "treat to target" approach. Our use of concomitant methotrexate/leflunomide is less than we would have liked and thought, but our use of concomitant corticosteroids is much less than normally seen. A single-center registry can provide useful monitoring and quality assurance data and stimulate change.

show abstract

A biologic pharmacosurveillance program for rheumatoid arthritis: a single-center experience

Russell

Mallon

Conner‐Spady

et al. 2013

Clin Rheumatol

View full text Add to dashboard Cite

show abstract

Bibliography Current World Literature

2012

Current Orthopaedic Practice

View full text Add to dashboard Cite

Clinical aspects of rheumatoid arthritis: highlights from the 2010 ACR conference (Part II)

Anandarajah¹

2011

International Journal of Clinical Rheumatology

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Reply

Cited by 3 publications

References 2 publications

A biologic pharmacosurveillance program for rheumatoid arthritis: a single-center experience

A biologic pharmacosurveillance program for rheumatoid arthritis: a single-center experience

Bibliography Current World Literature

Clinical aspects of rheumatoid arthritis: highlights from the 2010 ACR conference (Part II)

Contact Info

Product

Resources

About